NCT06177288 2023-12-20
DEBIRI
Fudan University
Phase NA Unknown
Clinical Trials
7 trialsNCT05811793 2023-04-13
Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT05407155 2022-06-07
BETTER
Fudan University
Phase NA Unknown
NCT04944069 2021-06-29
ATTRACT
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT01939574 2016-01-21
A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Shandong Cancer Hospital and Institute
Phase NA Unknown
NCT02208128 2014-08-04
MORE
Heidelberg University
Phase NA Unknown
NCT00436709 2014-01-06
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown